Compliance to a Hormone Therapy Regimen in Breast Cancer
Completed
Conditions studied: Breast Cancer
In brief
RATIONALE: Understanding how well patients comply with their treatment regimen may help doctors plan the best treatment and ongoing care. PURPOSE: This clinical trial is studying whether patients comply with their hormone therapy regimen in women with estrogen receptor-positive stage I, stage II, or stage IIIA breast cancer.
Key facts
- Study ID
- NCT00666822
- Run by
- Case Comprehensive Cancer Center
- People needed
- 178
- Starts
- 2007-12-01
- Expected to finish
- 2015-12-01
- Last updated by the study team
- 2016-02-05
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.